Antonio Ciaramella

Summary

Affiliation: Fondazione Santa Lucia
Country: Italy

Publications

  1. ncbi Amyloid beta peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells
    Antonio Ciaramella
    Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Via Ardeatina 306, 00179 Rome, Italy
    Neurobiol Aging 30:210-21. 2009
  2. ncbi Effect of age on surface molecules and cytokine expression in human dendritic cells
    Antonio Ciaramella
    Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Via Ardeatina 306, 00179 Rome, Italy
    Cell Immunol 269:82-9. 2011
  3. ncbi Increased pro-inflammatory response by dendritic cells from patients with Alzheimer's disease
    Antonio Ciaramella
    Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
    J Alzheimers Dis 19:559-72. 2010
  4. ncbi Interleukin-18 produced by peripheral blood cells is increased in Alzheimer's disease and correlates with cognitive impairment
    Paola Bossù
    IRCCS Santa Lucia Foundation, Department of Clinical and Behavioural Neurology, Via Ardeatina 306, 00179 Rome, Italy
    Brain Behav Immun 22:487-92. 2008
  5. ncbi Increased expression of Interleukin-18 receptor in blood cells of subjects with Mild Cognitive Impairment and Alzheimer's disease
    Francesca Salani
    Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Via Ardeatina 306, I 00179 Rome, Italy
    Cytokine 61:360-3. 2013
  6. ncbi Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia
    Ilaria Palladino
    Clinical and Behavioral Neurology, IRCCS Fondazione Santa Lucia, Via Ardeatina 306, 00179 Rome, Italy
    J Neuroinflammation 9:206. 2012
  7. ncbi Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels
    Francesco Angelucci
    Department of Clinical and Behavioural Neurology, 00179, Rome, Italy
    Curr Alzheimer Res 7:15-20. 2010
  8. ncbi Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease
    Paola Bossù
    IRCCS Santa Lucia Foundation, Rome, Italy
    J Neurol Neurosurg Psychiatry 78:807-11. 2007
  9. ncbi IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease
    Paola Bossù
    Laboratory of Clinical and Behavioral Neurology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia, 00179 Rome, Italy
    Proc Natl Acad Sci U S A 100:14181-6. 2003

Collaborators

Detail Information

Publications9

  1. ncbi Amyloid beta peptide promotes differentiation of pro-inflammatory human myeloid dendritic cells
    Antonio Ciaramella
    Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Via Ardeatina 306, 00179 Rome, Italy
    Neurobiol Aging 30:210-21. 2009
    ..These results demonstrate that A beta 42 can modulate the immune system by inducing pro-inflammatory DC differentiation, thus gaining new insights into AD pathogenesis and immune-based therapeutic intervention...
  2. ncbi Effect of age on surface molecules and cytokine expression in human dendritic cells
    Antonio Ciaramella
    Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Via Ardeatina 306, 00179 Rome, Italy
    Cell Immunol 269:82-9. 2011
    ..Altogether, the present results point to additional molecules whose role might be relevant in immunosenescence of human DCs, confirming that these cells undergo functional changes during aging...
  3. ncbi Increased pro-inflammatory response by dendritic cells from patients with Alzheimer's disease
    Antonio Ciaramella
    Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
    J Alzheimers Dis 19:559-72. 2010
    ....
  4. ncbi Interleukin-18 produced by peripheral blood cells is increased in Alzheimer's disease and correlates with cognitive impairment
    Paola Bossù
    IRCCS Santa Lucia Foundation, Department of Clinical and Behavioural Neurology, Via Ardeatina 306, 00179 Rome, Italy
    Brain Behav Immun 22:487-92. 2008
    ....
  5. ncbi Increased expression of Interleukin-18 receptor in blood cells of subjects with Mild Cognitive Impairment and Alzheimer's disease
    Francesca Salani
    Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Via Ardeatina 306, I 00179 Rome, Italy
    Cytokine 61:360-3. 2013
    ....
  6. ncbi Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia
    Ilaria Palladino
    Clinical and Behavioral Neurology, IRCCS Fondazione Santa Lucia, Via Ardeatina 306, 00179 Rome, Italy
    J Neuroinflammation 9:206. 2012
    ....
  7. ncbi Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels
    Francesco Angelucci
    Department of Clinical and Behavioural Neurology, 00179, Rome, Italy
    Curr Alzheimer Res 7:15-20. 2010
    ..Other studies are necessary to establish a direct link between BDNF peripheral levels and AD longitudinal course, as well as the role of other factors, such as blood cell activation, in determining these events...
  8. ncbi Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease
    Paola Bossù
    IRCCS Santa Lucia Foundation, Rome, Italy
    J Neurol Neurosurg Psychiatry 78:807-11. 2007
    ..The aim of this study was to investigate the impact of two polymorphisms of the human IL-18 gene promoter at positions -607 (C/A) and -137 (G/C) on both susceptibility to and progression of AD...
  9. ncbi IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease
    Paola Bossù
    Laboratory of Clinical and Behavioral Neurology, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Santa Lucia, 00179 Rome, Italy
    Proc Natl Acad Sci U S A 100:14181-6. 2003
    ..These studies support the concept that IL-18 plays a major role in the pathogenesis of the autoimmune syndrome of lpr mice and that a reduction in IL-18 activity could be a therapeutic strategy in autoimmune diseases...